Company News

Sederma’s Latest Rollout Ideal for Brightening Skin

Skin care formulations benefit from Wonderlight.

Author Image

By: TOM BRANNA

Editor

Management of the epidermal melanin unit cross-talking pigmentation disorders are a big concern widely shared by most of the populations (Asian, African, Latin-American people). Amongst benign pigmentation disorders, some are stimulated by aging (freckles, lentigines and melasma) and stress (inflammatory hyperpigmentation).

Sederma is proud to offer a new solution to people wishing to reduce irregularities in pigmentation or to brighten their skin complexion. Based on a botanical, Wonderlight acts on both melanocytes and their associated keratinocytes to help lessen pigmentation disorders. It reduces the Epidermal Melanin Unit cross-talking and blocks the signaling pathways involved in the melanin synthesis. Wonderlight exhibits a stronger effect on hyper pigmented areas and equalises skin pigmentation in order to make them less visible.

The ability of Wonderlight to inhibit the UV inducted secretion of GM-CSF (important melanocyte stimulator) was demonstrated in vitro. The concept was validated on living human skin cultures (phototype III) in which the UVAB induced 2- fold increase in the number of melanocytes was totally inhibited in the presence of Wonderlight.
Wonderlight is preservative free and is approved for Japan.

Keep Up With Our Content. Subscribe To Happi Newsletters